{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T22:35:53Z","timestamp":1789425353294,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","issue":"39","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,8,24]],"date-time":"2015-08-24T00:00:00Z","timestamp":1440374400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014588","name":"Sanofi Pasteur","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014588","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.vaccine.2015.08.008","type":"journal-article","created":{"date-parts":[[2015,8,13]],"date-time":"2015-08-13T15:50:01Z","timestamp":1439481001000},"page":"5127-5134","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Lot-to-lot consistency of a tetravalent dengue vaccine in healthy adults in Australia: A randomised study"],"prefix":"10.1016","volume":"33","author":[{"given":"Joseph","family":"Torresi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon G.","family":"Heron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Marjason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Chambonneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Bouckenooghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Boaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"van der Vliet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanee","family":"Hutagalung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Nissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Richmond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.08.008_bib0155","series-title":"Global strategy for dengue prevention and control: 2012\u20132020","author":"World Health Organization","year":"2012"},{"key":"10.1016\/j.vaccine.2015.08.008_bib0160","doi-asserted-by":"crossref","first-page":"6242","DOI":"10.1073\/pnas.0508391103","article-title":"Global traffic and disease vector dispersal","volume":"103","author":"Tatem","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2015.08.008_bib0165","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nature12060","article-title":"The global distribution and burden of dengue","volume":"496","author":"Bhatt","year":"2013","journal-title":"Nature"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2015.08.008_bib0170","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1590\/S0102-311X2009001300003","article-title":"Dengue in the Americas: challenges for prevention and control","volume":"25","author":"Gomez-Dantes","year":"2009","journal-title":"Cad Saude Publica"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2015.08.008_bib0175","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1179\/2046904712Z.00000000046","article-title":"Dengue: an escalating public health problem in Latin America","volume":"32","author":"Tapia-Conyer","year":"2012","journal-title":"Paediatr Int Child Health"},{"key":"10.1016\/j.vaccine.2015.08.008_bib0180","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1128\/CMR.11.3.480","article-title":"Dengue and dengue hemorrhagic fever","volume":"11","author":"Gubler","year":"1998","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2015.08.008_bib0185","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1007\/s10096-011-1429-1","article-title":"Incidence and seroprevalence of dengue virus infections in Australian travellers to Asia","volume":"31","author":"Ratnam","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2015.08.008_bib0190","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1056\/NEJMoa051331","article-title":"Spectrum of disease and relation to place of exposure among ill returned travelers","volume":"354","author":"Freedman","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2015.08.008_bib0195","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.tmaid.2013.06.008","article-title":"Seroepidemiology of dengue in travellers: a paired sera analysis","volume":"11","author":"Leder","year":"2013","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.vaccine.2015.08.008_bib0200","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1016\/j.vaccine.2011.03.057","article-title":"Live-attenuated, tetravalent dengue vaccine in children, adolescents and adults in a dengue endemic country: randomized controlled phase I trial in the Philippines","volume":"29","author":"Capeding","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.08.008_bib0205","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/S0140-6736(12)61428-7","article-title":"Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial","volume":"380","author":"Sabchareon","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2015.08.008_bib0210","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1097\/INF.0b013e3181fe05af","article-title":"Live-attenuated tetravalent dengue vaccine in dengue-naive children, adolescents, and adults in Mexico City: randomized controlled phase 1 trial of safety and immunogenicity","volume":"30","author":"Poo","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2015.08.008_bib0215","series-title":"Presented at: IDweek 2012","article-title":"Immunogenicity and safety of three formulations of a tetravalent dengue vaccine candidate among healthy adults in the US","author":"Johnson","year":"2012"},{"key":"10.1016\/j.vaccine.2015.08.008_bib0220","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1086\/649916","article-title":"A novel tetravalent dengue vaccine is well tolerated and immunogenic against all 4 serotypes in flavivirus-naive adults","volume":"201","author":"Morrison","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.08.008_bib0225","doi-asserted-by":"crossref","first-page":"5935","DOI":"10.1016\/j.vaccine.2012.07.043","article-title":"Immunogenicity and safety of tetravalent dengue vaccine in 2\u201311 year-olds previously vaccinated against yellow fever: randomized, controlled, phase II study in Piura, Peru","volume":"30","author":"Lanata","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.08.008_bib0230","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.4161\/hv.21224","article-title":"Immunogenicity and safety of recombinant tetravalent dengue vaccine (CYD-TDV) in individuals aged 2\u201345 y: phase II randomized controlled trial in Singapore","volume":"8","author":"Leo","year":"2012","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2015.08.008_bib0235","first-page":"1000162","article-title":"Safety and immunogenicity of recombinant, live attenuated tetravalent dengue vaccine (CYD-TDV) in healthy Vietnamese adults and children","volume":"3","author":"Tran","year":"2012","journal-title":"J Vaccines Vaccin"},{"issue":"Suppl 18","key":"10.1016\/j.vaccine.2015.08.008_bib0240","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1590\/S0036-46652012000700007","article-title":"Development of Sanofi Pasteur tetravalent dengue vaccine","volume":"54","author":"Lang","year":"2012","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"10.1016\/j.vaccine.2015.08.008_bib0245","doi-asserted-by":"crossref","first-page":"7229","DOI":"10.1016\/j.vaccine.2011.06.094","article-title":"From research to phase III: preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine","volume":"29","author":"Guy","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.08.008_bib0250","series-title":"Clinical considerations for evaluation of vaccines for prequalification. Points to consider for manufacturers of human vaccines","author":"World Health Organization","year":"2010"},{"key":"10.1016\/j.vaccine.2015.08.008_bib0255","doi-asserted-by":"crossref","first-page":"724","DOI":"10.4269\/ajtmh.2011.10-0436","article-title":"Priming effect of dengue and yellow fever vaccination on the immunogenicity, infectivity, and safety of a tetravalent dengue vaccine in humans","volume":"85","author":"Qiao","year":"2011","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2015.08.008_bib0260","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.4269\/ajtmh.13-0304","article-title":"Immunogenicity and safety of a recombinant tetravalent dengue vaccine in children and adolescents ages 9\u201316 years in Brazil","volume":"89","author":"Dayan","year":"2013","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2015.08.008_bib0265","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1097\/INF.0b013e31829b8022","article-title":"Safety and immunogenicity of a recombinant tetravalent dengue vaccine in 9\u201316 year olds: a randomized, controlled, phase II trial in Latin America","volume":"32","author":"Villar","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2015.08.008_bib0270","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1089\/vim.2008.0007","article-title":"Guidelines for plaque-reduction neutralization testing of human antibodies to dengue viruses","volume":"21","author":"Roehrig","year":"2008","journal-title":"Viral Immunol"},{"key":"10.1016\/j.vaccine.2015.08.008_bib0275","doi-asserted-by":"crossref","first-page":"962","DOI":"10.4269\/ajtmh.12-0461","article-title":"Optimization and validation of a plaque reduction neutralization test for the detection of neutralizing antibodies to four serotypes of dengue virus used in support of dengue vaccine development","volume":"88","author":"Timiryasova","year":"2013","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2015.08.008_bib0280","series-title":"Guidelines for prevention and control of dengue and dengue haemorrhagic fever","author":"World Health Organization","year":"1999"},{"key":"10.1016\/j.vaccine.2015.08.008_bib0285","series-title":"safety and efficacy of dengue tetravalent vaccines (live, attenuated)","article-title":"World Health Organization. Guidelines on the quality","author":"World Health Organization","year":"2011"},{"key":"10.1016\/j.vaccine.2015.08.008_bib0290","series-title":"Guidelines for plaque reduction neutralization testing of human antibodies to dengue viruses","author":"World Health Organization","year":"2007"},{"key":"10.1016\/j.vaccine.2015.08.008_bib0295","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/S0140-6736(14)61060-6","article-title":"Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial","volume":"384","author":"Capeding","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2015.08.008_bib0300","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1056\/NEJMoa1411037","article-title":"Efficacy of a tetravalent dengue vaccine in children in Latin America","volume":"372","author":"Villar","year":"2015","journal-title":"N Engl J Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15011226?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15011226?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T23:04:58Z","timestamp":1668639898000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15011226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":30,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0264410X15011226"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.08.008","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lot-to-lot consistency of a tetravalent dengue vaccine in healthy adults in Australia: A randomised study","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}